Citigroup’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-300
Closed -$3K 7635
2020
Q2
$3K Sell
300
-900
-75% -$10.2K ﹤0.01% 7365
2020
Q1
$12K Buy
1,200
+600
+100% +$7.44K ﹤0.01% 6979
2019
Q4
$10K Buy
+600
New +$9.07K ﹤0.01% 7215
2019
Q3
Sell
-5,300
Closed -$75K 7837
2019
Q2
$75K Sell
5,300
-9,200
-63% -$146K ﹤0.01% 6135
2019
Q1
$267K Buy
14,500
+7,800
+116% +$178K ﹤0.01% 4822
2018
Q4
$175K Buy
6,700
+6,500
+3,250% +$153K ﹤0.01% 5148
2018
Q3
$5K Sell
200
-1,900
-90% -$38.8K ﹤0.01% 7503
2018
Q2
$40K Buy
2,100
+2,000
+2,000% +$33.4K ﹤0.01% 6461
2018
Q1
$2K Sell
100
-400
-80% -$6.7K ﹤0.01% 7382
2017
Q4
$8K Hold
500
﹤0.01% 7120
2017
Q3
$9K Buy
500
+400
+400% +$6.69K ﹤0.01% 6729
2017
Q2
$2K Sell
100
-7,000
-99% -$101K ﹤0.01% 7032
2017
Q1
$99K Buy
7,100
+2,200
+45% +$31.4K ﹤0.01% 5226
2016
Q4
$78K Sell
4,900
-500
-9% -$8.04K ﹤0.01% 5916
2016
Q3
$90K Buy
5,400
+3,000
+125% +$40.4K ﹤0.01% 5276
2016
Q2
$27K Buy
2,400
+600
+33% +$5.81K ﹤0.01% 5983
2016
Q1
$15K Buy
+1,800
New +$14.8K ﹤0.01% 6671

Other funds holding VNDA